Clinical Trial Update: Desmopressin Melt: Impact on Sleep and Daytime Functioning [Phase 4]

View source ↗

Summary

Phase 4 trial update on desmopressin melt assessing impact on sleep and daytime functioning in monosymptomatic nocturnal enuresis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monosymptomatic Nocturnal Enuresis

Drugs mentioned

• Desmopressin Melt (desmopressin)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Monosymptomatic Nocturnal Enuresis | Phase 4 | Status: COMPLETED